April 19, 2025 - 00:24

If we want to find a stock that could multiply over the long term, it’s essential to focus on specific underlying trends that indicate strong performance potential. One critical metric to consider is Return on Capital Employed (ROCE), which measures a company's efficiency in generating profits from its capital. A consistent or improving ROCE can signal that a company is effectively utilizing its resources to drive growth.
Investors should also pay attention to revenue growth rates and profit margins, as these factors contribute to overall financial health. A company that demonstrates robust revenue growth alongside stable or increasing profit margins is often better positioned to deliver long-term returns. Additionally, assessing the competitive landscape, technological advancements, and market demand can provide insights into a company's future prospects.
Ultimately, a combination of strong ROCE, healthy revenue growth, and favorable market conditions can create a compelling case for investors seeking stocks with significant long-term appreciation potential.
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...